Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania



Status:Recruiting
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:5/13/2018
Start Date:May 10, 2018
End Date:December 31, 2019
Contact:David A.F. Haaga, Ph.D.
Email:dhaaga@american.edu
Phone:202-885-1718

Use our guide to learn which trials are right for you!

Randomized Controlled Trial of the Comprehensive Behavioral (ComB) Model of Treatment for Trichotillomania

This study will be the first randomized controlled trial of Comprehensive Behavior
Modification (ComB) as a treatment of trichotillomania (TTM). ComB treatment (12 weekly
sessions, following a manual developed in an earlier treatment development project) will be
compared to Minimal Attention Control among adults (N = 42) with TTM.

Treatment based on the ComB model has been influential in the field of body-focused
repetitive behaviors (BFRB's), but there is limited empirical research on its efficacy. Our
first project (Falkenstein et al., 2016) developed a 12-session manual for ComB and a method
for evaluating therapist adherence to the model that can be used reliably and provided
encouraging (uncontrolled) data on the effects of ComB through 3-month follow-up.

The proposed project extends the earlier work in two main ways: (a) using random assignment
to ComB vs. comparison condition to test whether ComB works better than the passage of time +
demand characteristics of being in a TTM study alone; and (b) gathering initial evidence on
how ComB works.

Treatment will be conducted at two sites -- Washington, DC (American University and the
Behavior Therapy Center of Greater Washington) and Chicago (University of Chicago).
Participants in the Minimal Attention Control condition will receive ComB therapy after the
post-treatment [week 12] assessment is conducted. Uncontrolled follow-up data will be
collected through 3 (MAC condition) or 6 (immediate ComB condition) months after the end of
ComB treatment.

Inclusion Criteria:

- 18 years of age or older

- diagnosed with Trichotillomania

- medication type and dosage [if any] stable for at least 3 months

Exclusion Criteria:

- active suicidality

--probable bipolar disorder

- probable psychosis

- other pressing clinical problem requiring immediate treatment

- current psychotherapy and unable/unwilling to discontinue
We found this trial at
1
site
Washington, District of Columbia 20014
?
mi
from
Washington,
Click here to add this to my saved trials